Category: Regulation and Deregulation of Industry

E.P.A. Again Seeks Limits on a Harmful Pesticide

After a court overturned a ban, the agency has proposed restricting chlorpyrifos to 11 food crops, illustrating the limits of federal regulation.
North Carolina Town Sues Duke Energy Over Climate Change

Carrboro accused Duke, one the nation’s largest utility companies, of ignoring data about climate change while increasing use of fossil fuels.
McDonald’s E Coli Outbreak Declared Over

Federal health agencies closed their investigations into the bacterial outbreak that sickened 104 people and was linked to onions on the fast-food chain’s signature Quarter Pounders.
Nursing Home Industry Wants Trump to Rescind Staffing Mandate

A Biden administration rule that imposed minimum rules on nursing levels may not survive, even though many homes lack enough workers to maintain residents’ care.
F.T.C. Launches Antitrust Investigation Into Microsoft

Regulators are demanding information from the company on its cloud computing, artificial intelligence and cybersecurity products.
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics

When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.
Fed Minutes Show Options Are Open on Interest Rate Cuts

Minutes from a Nov. 6-7 meeting showed that Federal Reserve policymakers saw the labor market stabilizing and signs of economic strength.
China’s Police Are Preying on Small Firms in Search of Cash

With localities facing budget holes, the police are crossing provincial borders to collect fines and draining company treasuries. Businesses call it a shakedown.
Margrethe Vestager, the World’s Top Tech Cop, Is Making Her Exit

Margrethe Vestager, the European Union’s antitrust regulator, who put technology’s harms on the global agenda, reflected on a decade of taking on the biggest companies and what comes next.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
U.S. Says Google Is an Ad Tech Monopolist, in Closing Arguments

The two sides made their final cases to a federal judge Monday in a trial over the tech giant’s dominance in technology that sells ads online.